BioMedNewsBreaks – Adial Pharmaceuticals Inc (NASDAQ: ADIL) Featured by M-Vest
Feb 5, 2021
Adial Pharmaceuticals (NASDAQ: ADIL), a clinical-stage biopharmaceutical company, was recently highlighted as a featured company by M-Vest. The update reads, “Adial has created an investigational attendant diagnostic biomarker blood test for the genetic screening of patients with certain biomarkers that, as reported in the American Journal of Psychiatry (Johnson, et. al. 2011 & 2013), Adial believes make patients more likely to benefit from treatment with AD04. Adial’s strategy is to integrate pre-treatment genetic screening into AD04’s label to create a patient-specific treatment in one integrated therapeutic offering. Adial’s goal is to develop a genetically targeted, effective and safe product candidate to treat AUD that does not require abstinence as part of the treatment.”
For more details, visit https://ibn.fm/nCHOc
About Adial Pharmaceuticals Inc.
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The company’s lead investigational new drug product, AD04, is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (“AUD”) and is currently being investigated in a Phase 3 clinical for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the company’s proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as opioid use disorder, gambling and obesity. For more information about the company, visit www.AdialPharma.com.
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Six Flags Closes Multiple Rides After Death on Georgia Roller Coaster
One rider died and several others were injured at Six Flags Over Georgia, the police said. The company said it was temporarily closing nine rides in the U.S. and Canada as a precaution.
UK growth forecast upgraded but higher energy prices to hit economy next year
The prediction from the IMF comes as final preparations are being made for the first Budget under Prime Minister Andy Burnham.
Phase Eight and Hobbs owner hit by cyber-attack, as H&M probes separate hack claim
TFG London has apologised to customers for disruption after it identified a "cybersecurity incident" on Sunday.
Hillary Clinton Steps to the Podcast Mic as Midterms Approach
With “High Stakes,” Mrs. Clinton is teaming up with “Pivot” co-host Kara Swisher to break down the consequential battle for the House and the Senate.
How Climate Change Is Causing ‘the Gentrification of Seafood’
As environmental forces make fishing and harvesting more costly, the price of once-everyday fish has ballooned.
States Now Have to Decide How to Spend Meta’s Settlement Billions
Previous agreements with the tobacco and opioid industries show the difficulty of putting the money in the right hands.
Cost of living struggles inspire 'social supermarket'
New social supermarket offers cheaper groceries with dignity and choice.
I.M.F. Warns Mideast War Will Widen Gap Between Rich and Poor Countries
Persistent conflicts, high energy costs and technological upheavals will slow global growth and raise prices, the organization forecast.
Airfares Have Spiked. Is the Death of Spirit Airlines to Blame?
In the wake of the ultra-low-cost carrier’s closure, and with the cost of fuel and labor rising, domestic fares have become less competitive. But there are ways to parry higher prices.
Foreign diplomats embrace China's livestream commerce
Foreign diplomats embrace China's livestream commerce
Dating app Bumble in $1bn takeover talks, say reports
The dating app which recently ditched its "women-first" chat rule could be bought by an investment firm.
Chinese vice premier meets with Apple executive chairman
Chinese Vice Premier He Lifeng, also a member of the Political Bureau of the Communist Party of China Central Committee, met with Tim Cook, executive chairman of the board of directors of Apple Inc., at the Great Hall of the People in Beijing on Monday.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.